Adrián Abad Fustero, supply chain director of Medis, will be presenting at FutureLink Munich on the ‘The Virtual Broker: Negotiating Win-Wins with Track & Trace Partners’. In a preview of his presentation, we interviewed Fustero on the role of brokers in Falsified Medicines Directive (FMD) serialisation programmes.
Negotiations
Middle brokers have a unique challenge when it comes to serialisation. They have vested interests in both marketing authorisation holders (MAHs) and contract manufacturers (CMOs) and must understand everything to be able to support compliance efforts throughout the supply chain.